The Dividend Payout Ratio is the measure of dividends paid out to shareholders relative to the company's net income. It is calculated as the Dividends per Share divided by the Earnings per Share (Diluted) during the same time period. Genomma Lab InternacionalB de CV's Dividend Payout Ratio for the
months ended in Mar. 2026 was 0.34.
The historical rank and industry rank for Genomma Lab InternacionalB de CV's Dividend Payout Ratio or its related term are showing as below:
MEX:LABB'
s Dividend Payout Ratio Range Over the Past 10 Years
Min: 0.33 Med: 0.45 Max: 0.75
Current: 0.43
During the past 13 years, the highest Dividend Payout Ratio of Genomma Lab InternacionalB de CV was 0.75. The lowest was 0.33. And the median was 0.45.
MEX:LABB's Dividend Payout Ratio is ranked worse than 56.76% of 444
companies
in the Drug Manufacturers industry
Industry Median: 0.375
vs MEX:LABB: 0.43
During the past 13 years, the highest Trailing Annual Dividend Yield of Genomma Lab InternacionalB de CV was 11.60%. The lowest was 2.80%. And the median was 4.47%.
During the past 3 years, the average Dividends Per Share Growth Rate was -11.30% per year.
During the past 13 years, the highest 3-Year average Dividends Per Share Growth Rate of Genomma Lab InternacionalB de CV was -11.30% per year. The lowest was -11.40% per year. And the median was -11.35% per year.
The growth rate is calculated with least square regression.
For more information regarding to dividend, please check our Dividend Page.
* Please note that "special dividend" is not included in the calculation of dividend per share and related fields.
Genomma Lab InternacionalB de CV (MEX:LABB) Dividend Payout Ratio Explanation
In dividends investing, Dividend Payout Ratio and Dividend Growth Rate are the two most important variables for consideration. A lower payout ratio may indicate that the company has more room to increase its dividends.
Genomma Lab InternacionalB de CV Dividend Payout Ratio Related Terms
Genomma Lab InternacionalB de CV Dividend Payout Ratio Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Genomma Lab InternacionalB de CV Dividend Payout Ratio Chart
MEX:LABB vs ZTS, UTHR, VTRS: Dividend Payout Ratio Comparison
For the Drug Manufacturers - Specialty & Generic subindustry, Genomma Lab InternacionalB de CV's Dividend Payout Ratio, along with its competitors' market caps and Dividend Payout Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Genomma Lab InternacionalB de CV Dividend Payout Ratio vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Genomma Lab InternacionalB de CV's Dividend Payout Ratio distribution charts can be found below:
* The bar in red indicates where Genomma Lab InternacionalB de CV's Dividend Payout Ratio falls into.
Genomma Lab InternacionalB de CV Dividend Payout Ratio Calculation
The Dividend Payout Ratio is the measure of dividends paid out to shareholders relative to the company's net income. It is calculated as the Dividends per Share divided by the Earnings per Share (Diluted) during the same time period.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Genomma Lab InternacionalB de CV (MEX:LABB) has a Dividend Payout Ratio of 0.34 as of Mar. 2026. Dividend payout ratio is the percent of company earnings paid out as dividends. View historical data on Genomma Lab InternacionalB de CV and its competitors. This is 24% below median its historical median of 0.45. Over the past decade, Genomma Lab InternacionalB de CV's Dividend Payout Ratio has ranged from 0.33 to 0.75. According to the industry distribution chart, Genomma Lab InternacionalB de CV ranks #252 out of 444 companies in the Drug Manufacturers industry, placing it in the top 56.8%.
Is Genomma Lab InternacionalB de CV's Dividend Payout Ratio too high?
Genomma Lab InternacionalB de CV's current Dividend Payout Ratio of 0.34 is 24% below median its 10-year median of 0.45. Over the past 10 years, this metric has ranged from a low of 0.33 to a high of 0.75. The Drug Manufacturers industry median Dividend Payout Ratio is 0.38. Genomma Lab InternacionalB de CV's value of 0.34 is 9.3% below this industry median. Based on the distribution chart, Genomma Lab InternacionalB de CV ranks #252 out of 444 companies in the Drug Manufacturers industry, which is below the industry midpoint. Overall, Genomma Lab InternacionalB de CV has a GF Score™ of 66/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Genomma Lab InternacionalB de CV's Dividend Payout Ratio compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Genomma Lab InternacionalB de CV ranks #252 out of 444 companies for Dividend Payout Ratio. This places Genomma Lab InternacionalB de CV in the lower half of its industry. The industry median Dividend Payout Ratio is 0.38. Genomma Lab InternacionalB de CV's value of 0.34 is 9.3% below this benchmark. Historically, Genomma Lab InternacionalB de CV's own Dividend Payout Ratio has ranged from 0.33 to 0.75 over the past decade. While the company's 10-year median is 0.45 vs. the industry median of 0.38, Genomma Lab InternacionalB de CV has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Dividend Payout Ratio for a Drug Manufacturers company?
The median Dividend Payout Ratio among Drug Manufacturers companies is 0.38, based on 444 companies in the industry. Companies in the top quartile (top 25%) have a Dividend Payout Ratio significantly above this median, while those in the bottom quartile fall well below. However, Dividend Payout Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Genomma Lab InternacionalB de CV's current Dividend Payout Ratio of 0.34 is 9.3% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Dividend Payout Ratio mean?
A high Dividend Payout Ratio can signal that a stock is expensive relative to its fundamentals. Dividend payout ratio is the percent of company earnings paid out as dividends. View historical data on Genomma Lab InternacionalB de CV and its competitors. For the Drug Manufacturers industry, the median Dividend Payout Ratio is 0.38 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Genomma Lab InternacionalB de CV's current Dividend Payout Ratio is 0.34, which is 24% below median its own 10-year median of 0.45. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Genomma Lab InternacionalB de CV stock overvalued right now?
Based on GuruFocus' analysis, Genomma Lab InternacionalB de CV (MEX:LABB) is currently considered Modestly Undervalued. The stock's GF Value™ is MXN17.64, compared to a current price of MXN15.04 — trading 14.7% below its estimated fair value. The current Dividend Payout Ratio is 0.34, which is 24% below median its 10-year median of 0.45 and 9.3% below the Drug Manufacturers industry median of 0.38. Genomma Lab InternacionalB de CV's overall GF Score™ is 66/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Dividend Payout Ratio calculated?
Dividend Payout Ratio is calculated from a company's financial statements. For Genomma Lab InternacionalB de CV (MEX:LABB), the current Dividend Payout Ratio is 0.34 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Genomma Lab InternacionalB de CV (MEX:LABB) Overvalued in 2026?
Based on GuruFocus' analysis, Genomma Lab InternacionalB de CV stock appears to be undervalued.
The current stock price of MXN15.04 is trading 14.7% below its estimated GF Value™ of MXN17.64.
GuruFocus considers Genomma Lab InternacionalB de CV to be Modestly Undervalued.
Key valuation signals for MEX:LABB:
Dividend Payout Ratio: 0.34 (24% below median its 10-year median of 0.45)
GF Value™: MXN17.64 vs. price of MXN15.04 (14.7% below fair value)
Industry Position: 9.3% below the Drug Manufacturers median (#252 of 444)
No single metric tells the full story. See the MEX:LABB stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Genomma Lab InternacionalB de CV Business Description
Genomma Lab Internacional SAB de CV is a specialty and generic drug manufacturer. The company's stated goal is to improve and preserve the health and well-being of people through innovative, safe, and effective products. Genomma operates a wide variety of brands to serve different consumer needs, including pregnancy, pain medication, and deodorant. The company considers merger and acquisition investment as a potential component of its operational growth strategy for expanding its research, development, manufacturing, and marketing capabilities.
66GF Score
Get the complete analysis for MEX:LABB
Dividend Payout Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
MEX:LABB has been successfully added to your 
